Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company – investor.lilly.com
What HappenedLilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell. Source: Business – Latest – Google News. Read original report via sour…